MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is often treated with doxorubicin. MicroRNAs have been shown to have important regulatory roles in cancer and serve as a target in chemoresistance. In this study, we investigated the effects of specific microRNA-200a (miR-200a) on HCC tumor cell growth and effect of do...
Main Authors: | Xiao Cui, Dachen Zhou, Qiang Du, Peiqi Wan, Kun Dong, Hui Hou, David A. Geller |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523320303004 |
Similar Items
-
Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
by: Sameer A Dhayat, et al.
Published: (2015-01-01) -
The microRNA-200 family is upregulated in endometrial carcinoma.
by: Jaime Snowdon, et al.
Published: (2011-01-01) -
MicroRNA‐9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2
by: Xiangang Xu, et al.
Published: (2019-10-01) -
MicroRNA-200b suppresses the invasion and migration of hepatocellular carcinoma by downregulating RhoA and circRNA_000839
by: Ben-gang Wang, et al.
Published: (2017-07-01) -
Development of MicroRNA Therapeutics for Hepatocellular Carcinoma
by: Rajagopal N. Aravalli
Published: (2013-03-01)